What class of agents are targeted anticancer agents also known as?

Targeted anticancer agents are commonly referred to as biological response modifiers (BRMs). These agents work by specifically targeting molecular pathways and processes that are important in cancer cell proliferation, survival, and metastasis. Unlike traditional chemotherapeutic agents, which often affect rapidly dividing cells indiscriminately, targeted therapy is designed to interfere with specific molecules involved in the growth and spread of cancer.

This precision allows for a potentially enhanced therapeutic effect and reduced toxicity, as BRMs can spare normal cells to a greater extent compared to conventional treatments. The classification of targeted agents under biological response modifiers highlights their role in modifying the biological processes of cancer cells rather than simply killing rapidly dividing cells. This concept is key in modern oncology, emphasizing personalized treatment approaches based on the unique characteristics of individual tumors.